IMC Chicago
LEGN icon

IMC Chicago’s Legend Biotech LEGN Stock Holding History

IMC Chicago’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
55,800
+40,400
+262% +$1.09M ﹤0.01% 3292
2026
Q1 		$279K Buy
15,400
+2,500
+19% +$47.7K ﹤0.01% 4682
2025
Q4 		$280K Sell
12,900
-6,700
-34% -$192K ﹤0.01% 3840
2025
Q3 		$639K Buy
+19,600
New +$724K ﹤0.01% 3015

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

IMC Chicago's LEGN Position: Q2 2026 in Review

IMC Chicago sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 17,894 shares — an estimated $483K sold.

IMC Chicago first reported a position in LEGN in Q4 2025 and held it in 2 quarters. The position peaked at $499K in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • IMC Chicago reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 17,894 Legend Biotech shares in Q2 2026, an estimated $483K.
  • IMC Chicago first reported a position in Legend Biotech in Q4 2025 and held it in 2 quarters.
  • IMC Chicago's Legend Biotech position peaked at $499K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.